Home Octarine

Octarine

In operation
-
Advanced Cannabinoid and Psilocybin Derivatives Developer
Basic
Enterprise Profile

Basic Information

Octarine, a synthetic biology company, is dedicated to developing advanced cannabinoids and psilocybin derivatives. Using its unique biosynthesis platform, the company engineers microorganisms to produce a range of natural and novel cannabinoid and psilocybin-derived molecules, enhancing pharmacokinetics and therapeutic properties.
Octarine Bio ApS
Copenhagen,TheCapitalRegionofDenmark,Denmark
less than 15 people
January 01, 2018
info@octarinebio.com

Enterprise Profile

Industrial Sector
Biomanufacturing Compound Discovery Manufacture of Chemical Drug Active Pharmaceutical Ingredients
Technology
Microbial/Viral Technology Synthetic Biology
Concept
Disease Treatment Cannabis
Application Scenarios
Active Pharmaceutical Ingredient (API)